Global /South Korea /Healthcare /Drug Manufacturers - General /014950

Samik Pharmaceutical Company LTD.

014950

• KRX: 014950 • Delayed

9,920KRW 1.3%

6.53 USD

As of 14 June 2026, Samik Pharmaceutical Company LTD. has a market cap of $59.99M USD, ranking #29250 globally and #1593 in South Korea. It ranks #2646 in the Healthcare sector, and #941 in the Drug Manufacturers - General industry.

Global Rank

29250

Country Rank

1593

Sector Rank

2646

Industry Rank

941

Key Stats

Market Cap

$59.99MUSD

91.23B KRW

Enterprise Value

$40.95MUSD

62.18B KRW

Revenue (TTM)

$39.47MUSD

60.02B KRW

EBITDA (TTM)

$3.06MUSD

4.65B KRW

Net Income (TTM)

-$496.37KUSD

-754.89M KRW

EBITDA Margin

7.7%

Profit Margin

-1.3%

PS Ratio

1.5

PB Ratio

1.3

EV/EBITDA

13.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Choong-Hwan Lee open_in_new

Employees

134

Founded

1973

Website

samik.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.3%	-5%	-11%	-41%	-22%	-30%	-12%	-12%	-12%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	014950 ISIN: KR7014950000 Shares Out.: Shares Outstanding: 10.008M¹ Shares Float: 4.999M² TV: TradingView: KRX: 014950 SA: Stock Analysis: KRX: 014950 YF: Yahoo Finance: 014950.KS GF: Google Finance: KRX: 014950 BA: Barron's: 014950 MS: Morningstar: XKRX: 014950	9,920 KRW	TV: TradingView: KRX: 014950 SA: Stock Analysis: KRX: 014950 YF: Yahoo Finance: 014950.KS GF: Google Finance: KRX: 014950 BA: Barron's: 014950 MS: Morningstar: XKRX: 014950

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Samik Pharmaceutical Company LTD.

Samik Pharmaceutical Company LTD. develops and manufactures pharmaceuticals. The company offers oral therapeutic pharmaceuticals. It also provides drug compounds, drug delivery systems, drug repositioning, and reinforcement of biopharmaceuticals. The company was founded in 1973 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 15K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 11K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 9K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 8K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 912K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 601K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 536K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 481K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 458K%	20.5	Switzerland

chevron_leftBack